Individual Study / CaG
CARTaGENECARTaGENE
CARTaGENE is a long-term cohort study for the investigation of modifiable environmental and lifestyle factors and the genomic determinants of chronic diseases in Quebec, Canada.
Overview
- Website
- http://www.cartagene.qc.ca/en
- Investigators
-
-
Dr. Vikki Ho
Centre de recherche du CHUM -
Dr. Guillaume Lettre
Montreal Heart Institute Research Centre -
Dr. Simon Gravel
McGill University
-
Dr. Vikki Ho
- Contacts
-
-
Access Officer
CARTaGENE
-
Access Officer
Design
- General Information on Follow Up (profile, frequency)
- After two recruitment phases, A in 2009 and B in 2012, preceded by a pilot phase (2008), a first follow-up was realized in 2017. Further follow-ups are planned regularly.
- Recruitment target
-
- Individuals
- Target number of participants
- 43,046
- Target number of participants with biological samples
- 29,792
Access
Access to external researchers or third parties provided or foreseen for
- Data
- Biosamples
- Other
- Genetic data (Genotyping, RNA-seq, Whole Exome-seq, …)
Marker Paper
Awadalla P, Boileau C, Payette Y, Idaghdour Y, Goulet JP, Knoppers B, Hamet P, Laberge C, on behalf of the CP, Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics. Int J Epidemiol, 2013; 42:1285-1299.
PUBMED 23071140Timeline
Population
CaG population
The CaG cohort consists of men and women aged between 40 and 69 years residing in metropolitan areas of Quebec.
Selection criteria
- Minimum age
-
40
- Maximum age
-
69
- Countries
-
- Canada
- Territory
- Montreal, Quebec, Sherbrooke and Saguenay for Phase A. Trois-Rivières and Gatineau added in Phase B.
- Other criteria
- Participants were excluded if they were not registered in the FIPA files, if they resided outside the selected regions, lived in First Nations Reserves or long-term health care facilities or were in prison.
Sources of recruitment
- General population
-
- Selected sample
- Participants from existing studies
-
- Supplementary Information
- Participants were randomly chosen to be broadly representative of the population based on provincial health insurance registries—FIPA files (fichier administratif des inscriptions des personnes assurées de la Régie de l’assurance maladie du Québec (RAMQ)).
Sample Size
- Target number of participants
- 43,046
- Target number of participants with biological samples
- 29,792
- Supplementary information
-
Phase A: 20,004 participants
Phase B: 23,000 participants
Genealogical records’ number: 8,820
Data Collection Events
| # | Name | Data sources | Data sources - Biosamples | Start | End |
|---|---|---|---|---|---|
| 0 | CaG - Phase O |
|
|
2008 (February) | 2008 (February) |
| 1 | CaG - Phase A |
|
|
2009 (July) | 2010 (October) |
| 2 | CaG - Recontact Phase |
|
2011 (September) | 2012 (August) | |
| 3 | CaG - Phase B |
|
|
2012 (December) | 2015 (February) |
| 4 | CaG - Phase C |
|
2017 | 2018 |
Participating Studies
| Acronym | Name | Participants | Countries |
|---|
Harmonization Projects Included
| Acronym | Name |
|---|
Datasets
| Name | Type | data-collection-events | Variables |
|---|
Last Update: 2024-11-27T16:23:55.197